NeuroAMP: A Novel End-to-end General Purpose Deep Neural Amplifier for Personalized Hearing Aids
This work addresses the problem of improving hearing aid performance for users with hearing loss, though it is incremental as it builds on existing deep learning methods for audio processing.
The authors tackled the challenge of optimizing hearing aid amplification by developing NeuroAMP, an end-to-end deep neural network for personalized amplification, which achieved SRCC scores up to 0.9927 on speech quality metrics and a 10% improvement over conventional methods with its denoising extension.
The prevalence of hearing aids is increasing. However, optimizing the amplification processes of hearing aids remains challenging due to the complexity of integrating multiple modular components in traditional methods. To address this challenge, we present NeuroAMP, a novel deep neural network designed for end-to-end, personalized amplification in hearing aids. NeuroAMP leverages both spectral features and the listener's audiogram as inputs, and we investigate four architectures: Convolutional Neural Network (CNN), Long Short-Term Memory (LSTM), Convolutional Recurrent Neural Network (CRNN), and Transformer. We also introduce Denoising NeuroAMP, an extension that integrates noise reduction along with amplification capabilities for improved performance in real-world scenarios. To enhance generalization, a comprehensive data augmentation strategy was employed during training on diverse speech (TIMIT and TMHINT) and music (Cadenza Challenge MUSIC) datasets. Evaluation using the Hearing Aid Speech Perception Index (HASPI), Hearing Aid Speech Quality Index (HASQI), and Hearing Aid Audio Quality Index (HAAQI) demonstrates that the Transformer architecture within NeuroAMP achieves the best performance, with SRCC scores of 0.9927 (HASQI) and 0.9905 (HASPI) on TIMIT, and 0.9738 (HAAQI) on the Cadenza Challenge MUSIC dataset. Notably, our data augmentation strategy maintains high performance on unseen datasets (e.g., VCTK, MUSDB18-HQ). Furthermore, Denoising NeuroAMP outperforms both the conventional NAL-R+WDRC approach and a two-stage baseline on the VoiceBank+DEMAND dataset, achieving a 10% improvement in both HASPI (0.90) and HASQI (0.59) scores. These results highlight the potential of NeuroAMP and Denoising NeuroAMP to deliver notable improvements in personalized hearing aid amplification.